This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Uniquely Formulated for Powerful and Long-lasting Pain Relief
DUROLANE is a non-animal, high-molecular weight, stabilized hyaluronic acid. It is stabilized using a carefully controlled cross-linking process that increases the intra-articular residence time 1,26,29.
The process of lightly cross-linking hyaluronic acid molecules in DUROLANE (0.5%-1%) changes the physical properties of the hyaluronic acid, forming a three-dimensional gel 1,30.
This unique technology allows for a half-life of 4 weeks or 32 days in the joint, following a single-injection 26,29.
DUROLANE has a longer half-life than unstabilized hyaluronic acid or cross-linked Synvisc (hylan G-F 20) 31,32.
The most common side effects of DUROLANE in hip and knee studies were described as transient pain, stiffness and/or swelling localized to the joint. These adverse events were mild or moderate in intensity 33.
DUROLANE is safe for repeated courses of therapy. Studies investigating repeated treatment 6 months following the initial injection did not cause an increased rate of adverse events 33.
